Fund HoldingsDecheng Capital LLC

Total Portfolio Value
$395.97M
Total Bought
$5.96M
Total Sold
$22.89M
Net Transaction
-$16.93M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
AARDVARK THERAPEUTICS INC3,917,2993,917,299029,41952,96213.38%+23,543
Upstream Bio Inc.3,285,2933,285,293020,10636,0739.11%+15,967
CG ONCOLOGY INC(CGON)6,371,6696,371,6690156,042165,66341.84%+9,621
Nuvation Bio Inc.(NUVB)25,954,43925,954,439045,68050,61112.78%+4,931
BeyondSpring Inc.4,882,6514,531,481-351,1706,97210,6492.69%+3,677
MERUS NV189,098189,09807,9599,9472.51%+1,987
MOONLAKE IMMUNOTHERAPEUTICS171,600181,600+10,0006,7048,5722.16%+1,867
ARCELLX INC
COMMON STOCK
50,000547,609+497,6093,2804,4581.13%+1,178
REVOLUTION MEDICINES INC(NSM)(RVMD)226,000226,00007,9918,3152.10%+323
REZOLUTE INC059,900+59,90002670.07%+267
GRAIL INC(GRAL)9,6849,68402474980.13%+251
Aura Biosciences, Inc.515,555515,55503,0213,2270.82%+206
Nuvation Bio Inc.(NUVB)646,057646,0570441270.03%+83
Pyxis Oncology, Inc (formerly Apexigen)326,810326,81003203590.09%+39
VERA THERAPEUTICS INC(VERA)4,4950-4,4951080-108
Illumnia, Inc.(ILMN)11,7497,979-3,7709327610.19%-171
4D MOLECULAR THERAPEUTICS IN335,515239,510-96,0051,0848890.22%-195
Equillium Inc.4,447,3084,447,30801,7451,4020.35%-343
Aclaris Therapeutics, Inc.4,041,7364,041,73606,1845,7391.45%-445
Lyell Immunopharma, Inc.11,909,341595,466-11,313,8756,4075,2641.33%-1,143
Zentalis Pharmaceuticals Inc.2,019,7621,323,327-696,4353,2111,5350.39%-1,676
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
770,000770,000015,76213,9453.52%-1,817
Biontech SE-ADR(BNTX)20,0000-20,0001,8210-1,821
CRINETICS PHARMACEUTICALS IN(CRNX)177,958143,000-34,9585,9694,1131.04%-1,856
KRYSTAL BIOTECH INC(KRYS)65,00066,000+1,00011,7209,0722.29%-2,647
LEGEND BIOTECH CORP-ADR(LEGN)100,00020,000-80,0003,3937100.18%-2,683
CYTOKINETICS INC(CYTK)100,0000-100,0004,0190-4,019
Arcus Biosciences, Inc(RCUS)808,789160,000-648,7896,3498110.20%-5,538
Page 1 of 1